BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Drug Product News
Rhinomed (ASX:RNO) Release Of Next Generation Turbine Sports Technology 1/28/2015
Novartis AG (NVS) Sees Price War With Amgen (AMGN), Eli Lilly (LLY) for Blockbuster Psoriasis Market 1/28/2015
BioSpace (DHX) Poll Finds Whopping 92% of Respondents Believe Discounts Were Offered in Pricing War 1/27/2015
MSF Not Impressed With Pfizer (PFE)'s "Tiny" Vaccine Price Cut 1/27/2015
Merck & Co. (MRK)'s Fake MMR Trial Data Buried Even as Measles Outbreak Shows Vaccine Surge 1/27/2015
Asia's Biggest Vaccine Maker a Huge Threat to Drugmakers Like Merck & Co. (MRK) 1/27/2015
New England Biolabs Releases Rapid PNgase F For Biotherapeutic Development And Production 1/27/2015
IMPAX Laboratories, Inc. (IPXL) Receives FDA Approval For A Generic Version Of Lamictal® Orally Disintegrating Tablets (ODT) 1/26/2015
Purdue Pharma L.P. Release: Hysingla™ ER (hydrocodone bitartrate) Extended-Release Tablets CII Now Available 1/26/2015
Pfanstiehl Laboratories Launches New cGMP-produced, Parenteral Grade Maltose For Pharmaceutical Formulations 1/26/2015
Bogus Versions of Eli Lilly (LLY)'s Cialis Found Entering the U.S. By Mail, Says FDA 1/23/2015
After Gilead Sciences, Inc. (GILD)-AbbVie (ABBV)'s Hep C Price War, Express Scripts Inc. Eyes Cancer Meds Next 1/23/2015
NanoViricides, Inc. (NNVC.PK) Reports That It Has Shipped anti-Ebola Drug Candidates For Testing to a BSL-4 Hi-Security Biocontainment Laboratory 1/22/2015
Disneyland Measles Outbreak Casts Shadow on Anti-Vaccination Movement 1/21/2015
Boehringer Ingelheim Pharmaceuticals, Inc. Release: SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray Now Available In The United States 1/21/2015
International Charity Slams GlaxoSmithKline (GSK), Pfizer (PFE) for High Vaccine Prices 1/20/2015
IDEXX Laboratories, Inc. (IDXX) Announces SDMA As Important Expansion To Reference Lab Test Menu 1/19/2015
Elite Pharmaceuticals, Inc. (ELI) Announces First Shipment Of Generic Isradipine Capsules 1/16/2015
Mylan Inc. (MYL) Launches Generic Epivir-HBV® Tablets 1/16/2015
J.P. Morgan: AbbVie (ABBV) Getting "Very Compelling" Exclusive Offers for Viekira Pak, Says CFO 1/15/2015
Targets Of Next Express Scripts Inc. Price War: Amgen (AMGN) and Regeneron (REGN) 1/14/2015
Alimera Sciences (ALIM) Announces First Sale Of ILUVIEN® In Portugal 1/14/2015
Eli Lilly (LLY) Claims Innocence as FDA Bans Mystery Cialis-Viagra Concoction Discovered at Plant 1/14/2015
Breaking: J.P. Morgan: Sanofi (SAN.PA) Says Afrezza Will Be Available in 2015, Snubs MannKind Corporation (MNKD) CEO Retirement News 1/13/2015
Frost & Sullivan Releases Drug Launch And Phase 3 Trial Watch List For Top Therapeutic Areas 1/13/2015
Gilead Sciences, Inc. (GILD) Throws Another Punch at AbbVie (ABBV) by Striking Deal With Anthem, Inc. 1/12/2015
U.K. Cancer Drugs Fund Delists Big Pharmas' Meds; Novartis AG (NVS) Slams Process 1/12/2015
Hikma Pharmaceuticals (HIK.L) To Launch Colchicine 0.6mg Capsules 1/12/2015
HUYA Bioscience International Announces Regulatory Approval Of Chidamide, The First Selective HDAC Inhibitor In China 1/12/2015
Perrigo Company (PRGO) Launches The Generic Version Of Clobex® (Clobetasol Propionate) Spray, 0.05% 1/12/2015
Perrigo Company (PRGO) Launches AB Therapeutic Equivalent Testosterone Gel 1.0% 1/12/2015
Life Extension Introduces Immune Senescense Protection Formula 1/12/2015
Afaxys Announces Nationwide Availability Of Tarina Fe 1/20 To The Public Health Sector, Colleges & Universities 1/12/2015
Bioo Scientific Corporation Releases 18S ITS rRNA Library Prep Kit To Simplify Eukaryotic Metagenomic Studies 1/9/2015
Impax Pharmaceuticals (IPXL) Announce FDA Approval Of RYTARY™ (Carbidopa And Levodopa) Extended-Release Capsules For The Treatment Of Parkinson's Disease 1/8/2015
Gilead Sciences, Inc. (GILD) Fights Back as CVS Will Exclusively Cover Hepatitis C Drug Harvoni 1/7/2015
Lyophilization Services of New England Receives Approval To Manufacture Commercial Aseptic Product 1/7/2015
Teva Pharmaceutical Industries Limited (TEVA) Launches Generic Diovan® In The United States 1/7/2015
Fresenius Kabi AG Introduces NAROPIN® In Freeflex® Bag 1/6/2015
Lupin Ltd. (LUPN.BO) Launches Generic DIOVAN® Tablets 1/6/2015
NovaBay Pharmaceuticals, Inc. (NBY) Rebrands Its i-Lid Cleanser As Avenova 1/5/2015
Galderma Laboratories Launches Its First Over-The-Counter Acne Regimen, Benzac® Acne Solutions 1/5/2015
Mylan Inc. (MYL) Launches Generic Diovan® Tablets 1/5/2015
Newly-Approved Keryx Biopharmaceuticals (KERX) Drug Poised to Take About $600 Million of Genzyme Corporation (GENZ)'s Sales 1/2/2015
Sagent Pharmaceuticals, Inc. Announces The Launch Of Colistimethate For Injection, USP 12/30/2014
Novo Nordisk A/S (NVO) Plans to Use 500 Sales Reps to Promote New Obesity Drug 12/30/2014
UK Agency's Rejection of Eli Lilly (LLY), GlaxoSmithKline (GSK), PharmaMar S.A.'s Ovarian Cancer Drugs Stand 12/24/2014
Express Scripts Inc. Turns to AbbVie (ABBV) In Huge Hepatitis C Deal; Shuns Gilead Sciences, Inc. (GILD) 12/24/2014
PuraMed BioScience Nears Final Stages Needed For Distribution Of MigraPure H 12/23/2014
Keryx Biopharmaceuticals (KERX) Announces Commercial Launch Of AURYXIA™ (Ferric Citrate) Tablets In The United States 12/22/2014
Jazz Pharmaceuticals (JAZZ) Receives FDA Approval For Intravenous Administration Of Erwinaze® (Asparaginase Erwinia Chrysanthemi) 12/22/2014
Mylan Inc. (MYL) Launches First Generic Version Of Vivelle-DOT® 12/22/2014
Amgen (AMGN)'s Blincyto To Carry A Hefty $178,000 Price Tag 12/19/2014
NovoCure Ltd. Announces Optune Now Available At More Than 150 Leading Cancer Centers Across The United States 12/19/2014
NVN Therapeutics Launches Estracool™ Dietary Supplement For Reduction Of Menopausal Symptoms 12/18/2014
Putney, Inc. Launches Carprofen Chewable Tablets 12/18/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Valganciclovir Tablets, USP 12/16/2014
Actavis (ACT) Ordered To Keep Selling Alzheimer's Pill 12/12/2014
Pacira Pharmaceuticals, Inc. (PCRX) Announces Changes To EXPAREL® Label 12/12/2014
Doctors Who Promote More Expensive Eye Drug Are Among The Highest-Paid Genentech (RHHBY) Consultants 12/11/2014
Abbott Laboratories (ABT)'s Pioneering, Infectious Disease Testing Platform, IRIDICA, Now Available in Europe 12/11/2014
Mylan Inc. (MYL) Launches First Generic Version Of Orapred ODT 12/11/2014
Mylan Inc. (MYL) Launches Generic Robaxin Injection 12/11/2014
Lupin Ltd. (LUPN.BO) Launches Authorized Genericfor Celebrex Capsules 12/11/2014
Mylan Inc. (MYL) Launches One Of First Available Generic Versions Of Celebrex Capsules 12/10/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of First Generic Celebrex® Capsules In The United States 12/10/2014
Actavis (ACT) Launches Generic Version Of Celebrex 12/10/2014
S.F. Men Shed Condoms In Favor Of Gilead Sciences, Inc. (GILD)'s HIV Prevention Pill Truvada 12/9/2014
BioPharmX Corporation Release: Introducing Violet Iodine, New Once-Daily, Non-Prescription Pill For Relief Of Premenstrual Breast Discomfort* 12/9/2014
ConvaTec Introduces Sensi-Care Clear Zinc Skin Protectant For Diaper Rash 12/9/2014
Ignyta (RXDX) Receives Approval Of Nonproprietary Name Entrectinib For Lead Product Candidate, RXDX-101 12/9/2014
BioPharmX Corporation Release: Introducing Violet™ Iodine, New Once-Daily, Non-Prescription Pill For Relief Of Premenstrual Breast Discomfort 12/9/2014
Zydus Cadila Launches World's First Biosimilar Of AbbVie (ABBV)'s Humira In India 12/9/2014
Daiichi Sankyo, Inc. (4568.t) Launches New Formulation Of LIXIANA 60 mg Tablets (edoxaban) In Japan 12/8/2014
Otsuka Pharmaceutical Co., Ltd. Release: U.S. FDA Approves The Labeling Update Of Abilify Maintena® (Aripiprazole) For Extended-Release Injectable Suspension To Describe New Clinical Data For The Treatment Of Acutely Relapsed Adults With Schizophrenia 12/8/2014
Basilea Pharmaceutica (BSLN.SW) Announces Launch Of Antibiotic Zevtera(R) (Ceftobiprole Medocaril) In Germany 12/5/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved In Germany 12/4/2014
PTC Therapeutics, Inc. (PTCT) Announces Launch Of Translarna (ataluren) In Germany 12/3/2014
Galderma Laboratories, L.P. Release: The Cetaphil® Brand Launches New Cetaphil® Baby Line 12/3/2014
Suneva Medical Release: Bellafill To Replace ArteFill As New Brand 12/2/2014
EPIRUS Biopharmaceuticals Remicade® Biosimilar, Infimab™, Launches In India 12/2/2014
Pfanstiehl Laboratories Launches cGMP-Produced, Parenteral Grade Mannitol For Pharmaceutical Formulations 12/2/2014
Catylix And Aspira Scientific Launch The First Reagent For Pentafluoroethylation 12/2/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Exforge HCT® Tablets In The United States 12/1/2014
SkyePharma Inc. (SKYE)’s Partner Kyorin Pharmaceutical Co., Ltd. Launches 120-Puff Version Of Flutiform In Japan 12/1/2014
flutiform® Launched In Spain; Abriff® Launched In Italy SkyePharma Inc. (SKYE) To Receive €2 Million Milestone From Mundipharma International Limited 12/1/2014
Actavis (ACT) Launches Generic Version Of Intuniv 12/1/2014
FDA Warning: PML Death Associated With Biogen Idec (BIIB)'s Tecfidera 11/26/2014
IntelGenx Corp. Announces Update To Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/26/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Docetaxel Injection USP 11/24/2014
Perrigo Company (PRGO) Announces The Launch Of A Generic Version Of Astellas' Protopic Ointment 0.1% And 0.03% 11/24/2014
Sanofi (SAN.PA) Aims To Launch 18 New Drugs By 2020 11/21/2014
ViaDerma Lead Product TetraStem Shows Promise in Treating Acne 11/21/2014
IntelliPharmaCeutics Notes Launch Of 5mg Strength Of Focalin XR(R) Generic By Teva Pharmaceutical Industries Limited (TEVA) 11/20/2014
Endo International plc (ENDP) Announces Launch Of Generic Version Of Valcyte 11/20/2014
Amneal Pharmaceuticals Launches AG For Novo Nordisk A/S (NVO)’s Activella® 11/20/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Over-The-Counter Fexofenadine Hydrochloride 60 Mg And Pseudoephedrine Hydrochloride 120 Mg Extended-Release Tablets 11/20/2014
Keryx Biopharmaceuticals (KERX) Announces Trade Name Auryxia for Ferric Citrate 11/19/2014
AstraZeneca PLC (AZN) Shows Off Strong Drug Pipeline As Pfizer (PFE) Deadline Looms 11/18/2014
Pfizer (PFE) Release: TRUMENBA® (Meningococcal Group B Vaccine) Is Now Available 11/18/2014
Teva Pharmaceutical Industries Limited (TEVA) Launches Liquid Formulation Of TREANDA® (bendamustine HCI) Injection In U.S. 11/18/2014
Organovo Announces Commercial Release Of The exVive3D™ Human Liver Tissue 11/18/2014
Peli Biothermal Coolpall Vertos Launch Success In Europe 11/18/2014
Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex/ 11/18/2014
Galderma Laboratories Release: The Cetaphil® Brand Revamps RestoraDerm® Product Line 11/17/2014
Mallinckrodt Pharmaceuticals (MNK)'s Generic ADHD Drug Does Not Measure Up To Johnson & Johnson (JNJ)'s Concerta: FDA 11/14/2014
Mallinckrodt Pharmaceuticals (MNK) Responds To FDA’s Expected Reclassification Of Methylphenidate ER 11/14/2014
Kremers Urban Pharmaceuticals Inc. Informed By U.S. FDA Of ANDA Reclassification Of Methylphenidate ER 11/14/2014
Hep C King Gilead Sciences, Inc. (GILD)'s Harvoni Prescriptions Are Breaking Records 11/13/2014
Novartis AG (NVS) To Deliver Three Million Malaria Treatments For Kids In Zambia 11/13/2014
Major Medical Centers Ask Congress To Probe Genentech (RHHBY)'s Distribution Changes 11/13/2014
Five Percent Of Medicines In Malaysia Are Counterfeit: Pfizer (PFE) 11/11/2014
Oculus Innovative Sciences, Inc. (OCLS) Commercializes Microcyn®-Based Solution And Hydrogel For Treatment Of Mild-To-Moderate Acne In Europe 11/11/2014
Babies Die While Officials Haggle With Novartis AG (NVS) Over Cost Of Bexsero Vaccine 11/11/2014
Afaxys Pharmaceuticals Announces Wider National Availability Of ella® Emergency Contraceptive 11/11/2014
Endo Pharmaceuticals (ENDP) Receives Final Approval For Generic Version Of Valcyte® 11/10/2014
Eli Lilly (LLY)'s Trulicity™ (dulaglutide) Now Available In U.S. Pharmacies 11/10/2014
Tetrastem, Lead Product Of ViaDerma, Hopes To Slow Rates Of Diabetic Amputations 11/7/2014
ANI Pharmaceuticals, Inc. Announces The Launch Of Methazolamide Tablets USP 11/6/2014
Hospira, Inc. Announces U.S. Launch of Generic Paricalcitol Injection 11/6/2014
Mylan Inc. (MYL) Launches Generic Loestrin 24 Fe® 11/5/2014
Ranbaxy Laboratories (RANBAXY.BO) Receives Approval From FDA To Market Fenofibrate Capsules USP, 43 mg And 130 mg 11/5/2014
McNeil-PPC, Inc. Release: First FDA-Approved, Once Daily Application 5% Minoxidil Formula For Women Hits The Market 11/4/2014
Inergetics, Inc.' OmEssentials® Supplements Line Available At Whole Foods This Fall 11/4/2014
BioDelivery Sciences International (BDSI) Announces The Availability Of BUNAVAIL™ In The U.S. 11/3/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Novel Topical Treatment For Erectile Dysfunction In Belgium By Sandoz, Inc. 11/3/2014
Pharming Group (PHGUF.PK) And Salix Pharmaceuticals, Ltd. (SLXP) Announce The Launch Of Ruconest® In The U.S. For The Treatment Of Acute Angioedema Attacks In Patients With Hereditary Angioedema (HAE) 11/3/2014
Express Scripts Inc. Says AbbVie (ABBV)'s Drug Could Displace Gilead Sciences, Inc. (GILD)'s Sovaldi On Formulary 10/31/2014
Migranade, Inc. Release: Game Changing Migraine Medication To Be Available November 2014 10/31/2014
Omeros Corporation (OMER) Release: Omidria™ Granted Pass-Through Reimbursement Status From CMS 10/30/2014
Mylan Inc. (MYL) Launches Generic Viramune XR® 10/30/2014
When Will Biosimilars Impact The U.S. Market? 10/30/2014
Novo Nordisk A/S (NVO) Announces U.S. Launch Of NovoFine® Plus, A New Pen Needle For Patients With Diabetes 10/29/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Sirolimus Tablets, 1 mg And 2 mg 10/29/2014
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/28/2014
Fresenius Kabi AG Launches Kabiven® In The United States 10/27/2014
Octapharma AG Announces Octagam® 10% Now Available For Ordering In U.S. 10/27/2014
Pelvalon Announces New Analysis From The LIFE Pivotal Trial At The 2014 ICS Conference And Unveils The Brand Name For Its Vaginal Bowel Control Therapy 10/24/2014
European Medicines Agency Completes Review Of Polymyxin-Based Medicines 10/24/2014
BioSpace’s Favorite FDA Tricks Or Treats 10/24/2014
FDA Release: Gilead Sciences, Inc. (GILD)'s Harvoni® (ledipasvir/sofosbuvir) Approved For The Treatment Of Chronic Hepatitis C, Genotype 1 Infection In Adults; Diplomat To Distribute 10/23/2014
Tekmira (TKMR) Provides Periodic Update On TKM-Ebola Program 10/22/2014
Gilead Sciences, Inc. (GILD)'s $1,000-A-Pill Hepatitis C Drug May Make Financial Sense For Prisons 10/21/2014
Boehringer Ingelheim Pharmaceuticals, Inc. Release: OFEV® (nintedanib) Now Available In The United States 10/21/2014
Government Of Canada Ships NewLink Genetics' Ebola Vaccine To The WHO 10/20/2014
U.S. Regulators Ask Three Labs For Mapp Biopharmaceutical's ZMapp Ebola Plans 10/20/2014
Takeda Pharmaceuticals And Orexigen Therapeutics, Inc. (OREX) Announce Availability Of CONTRAVE® (naltrexone HCI And bupropion HCI) Extended-Release Tablets For Chronic Weight Management In Obese Adults 10/20/2014
Baxter International, Inc. (BAX) Launches HYQVIA In The United States For Adult Patients With Primary Immunodeficiency 10/20/2014
Admedus Cardiocel® To Be Launched In Canada 10/20/2014
Gilead Sciences, Inc. (GILD) Nervous As Johnson & Johnson (JNJ) Looks To Remain Competitive In Hepatitis C Market 10/16/2014
Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials 10/16/2014
Breckenridge Pharmaceutical, Inc. Announces Approval of Mefenamic Acid Capsules, USP 250mg 10/14/2014
Chimerix, Inc. (CMRX) Slips As Ebola Patient On Brincidofovir Dies 10/13/2014
PuraMed BioScience Nears Completion Of A Hemp-Derived-Cannabinoid-Based Non-Prescription Medication For Treatment Of Epilepsy Symptoms 10/13/2014
Health Canada Release: Safety Information On The Risk Of Blood Clots With Immunoglobulin Products 10/13/2014
Orexo AB (ORXOF) Submits Application To FDA For Expanded Label Of ZUBSOLV® 10/13/2014
Purdue Pharma L.P. Commercially Launches Recently Approved 7.5 Mcg/Hour Dosage Strength Of Butrans® (Buprenorphine) Transdermal System CIII 10/9/2014
Fujifilm Diosynth Biotechnologies Announces The Launch Of Its ‘Apollo™’ Mammalian Expression Platform 10/9/2014
Gilead Sciences, Inc. (GILD)'s Solvadi May Be Barred From UK's Service Plan 10/9/2014
Boehringer Ingelheim Corporation Release: New COPD Maintenance Treatment Striverdi® Respimat® (olodaterol) Inhalation Spray Now Available in U.S. Pharmacies 10/8/2014
Mylan Inc. (MYL) Launches Generic Combivir® 10/6/2014
Medac Pharma, Inc.'s Rasuvo (methotrexate) Injection Now Available For Patients With Rheumatoid Arthritis, Poly-Articular-Course Juvenile Idiopathic Arthritis And Psoriasis 10/6/2014
Ashland Inc.  (ASH) Announces Global Price Increase For Vinyl Pyrrolidone- And Cellulosic-Based Pharmaceutical Excipient Products 10/6/2014
AstraZeneca PLC (AZN) Release: BRILINTA Preferred Over Clopidogrel In 2014 American Heart Association/American College of Cardiology Guideline For The Management Of Non–ST-Elevation Acute Coronary Syndromes 10/6/2014
National Institute for Clinical Excellence (NICE) Rejects Another Roche (RHHBY) Leukemia Drug Citing Data Uncertainties 10/6/2014
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To Patients Infected With Ebola Virus 10/6/2014
Diploma PLC (DPLM.L) Release: Otezla® (apremilast) Receives Expanded Indication; Diplomat To Distribute 10/2/2014
Ranbaxy Laboratories (RANBAXY.BO) Launches ABSORICA® (isotretinoin) 25 Mg And 35 Mg Capsules In The U.S. Market 10/1/2014
Prollenium Medical Technologies Release: Lyracaine Topical Anesthetic Now Approved For Sale In Canada 10/1/2014
Pfizer (PFE) Starts New Viagra Commercials Targeting Women 9/30/2014
Mapp Biopharmaceutical's Ebola Drug Production Set for Texas, Possibly North Carolina 9/30/2014
Inergetics, Inc. Introduces Surgex® Warrior Sports Nutrition At Winn-Dixie 9/30/2014
LEO Pharma Announced New Taclonex® (Calcipotriene And Betamethasone Dipropionate) Topical Suspension, 0.005%/0.064% Indication For Treatment Of Scalp Plaque Psoriasis In Pediatric Patients Ages 12-17 9/30/2014
Par Pharmaceutical, Inc. Begins Shipment of Generic Exforge® 9/30/2014
Janssen-Cilag International NV (JNJ) Release: CHMP Announces Positive Opinion For REZOLSTA™, A New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir And Cobicistat 9/29/2014
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Available for the 2014/2015 Influenza Season 9/29/2014
Jaguar Animal Health, Inc. Launches First Product, Neonorm™ Calf, At World Dairy Expo 9/29/2014
Actavis (ACT) Will Keep Selling Alzheimer's Drug In U.S. For 60 Days 9/26/2014
FUJIFILM's Toyama Chemical Avigan Tablet 200mg Administered To A French Woman Infected With Ebola Virus 9/26/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Levalbuterol Inhalation Solution, USP 9/24/2014
Sagent Pharmaceuticals, Inc. Announces The Introduction Of Oxaliplatin Injection, USP 9/24/2014
Regeneron Pharmaceuticals, Inc. (REGN) R&D Chief Reveals Allergy Drug May Be Darling Of Its Pipeline 9/23/2014
Anacor Pharmaceuticals, Inc. (ANAC) Announces Commercial Launch Of KERYDIN (tavaborole) Topical Solution, 5% In The United States 9/23/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved For The European Union 9/22/2014
Lannett Company, Inc. (LCI) Launches Oxycodone Hydrochloride Oral Solution 9/22/2014
60 Percent Of New York’s Hep C Patients Will Get Gilead Sciences, Inc. (GILD)'s Sovaldi 9/19/2014
Sagent Pharmaceuticals, Inc. Announces The Launch Of Ketorolac Tromethamine Injection, USP 9/18/2014
Roche (RHHBY) Introduces A New Fertility Test For Assessment Of Ovarian Reserve For Pregnancy 9/18/2014
Janssen Pharmaceutical Inc. Release: Prezcobix™ Now Available For Canadians Living With HIV 9/17/2014
New Product From Vireo Systems: pH-D Feminine Health Support 9/17/2014
Novartis AG (NVS), Roche (RHHBY) Cry Foul On New Swiss Pricing System 9/16/2014
Bayer HealthCare (BAY) Announces The Launch Of Aleve® PM: The First And Only OTC PM Pain Reliever With A Sleep Aid Plus The 12-Hour Pain Relieving Strength Of Aleve 9/15/2014
Easton Pharmaceuticals (OP: EAPH) Announces Preparations For North American Product(s) Launch 9/15/2014
Roche (RHHBY) Battles Counterfeit Rituxin Vials In Germany 9/15/2014
The Medicines Company (MDCO) To Review ORBACTIV™ (Oritavancin) Launch Readiness On Tuesday, September 16, 2014 9/12/2014
The Obesity Society Release: New FDA-Approved Weight Loss Drug Adds New Tool For Obesity Treatment 9/11/2014
EMD Serono Canada Inc. Announces Launch Of The Eeva® Test In Canada 9/11/2014
Regeneus (RGS.AX) Kvax Cancer Vaccine Available In Australia, U.S. Trial Begins 9/11/2014
Cerilliant Corporation Snap-N-Spike® | Snap-N-Shoot® Certified Reference Materials Now Available Through Sigma-Aldrich Corporation (SIAL) 9/10/2014
Marathon Pharmaceuticals, LLC Launches Zingo® (Lidocaine Hydrochloride Monohydrate) Powder Intradermal Injection System, Topical Local Anesthetic To Manage Venous Access Pain 9/9/2014